views: 1383
Readers community rating: votes 0
1. Vzorov A.N., Weidmann A., Kozyr N.L. et al. Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection. Retrovirology. 2007; 4: 94. Doi:10.1186/1742-4690-4-94.
2. Owens R.J., Compans R.W. Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J. Virol. 1989; 63(2): 978–982. Available at: https://jvi.asm.org/content/63/2/978.
3. Tedbury P.R., Novikova M., Ablan S.D., Freed E.O. Biochemical evidence of a role for matrix trimerization in HIV-1 envelope glycoprotein incorporation. Proc. Natl. Acad. Sci. USA. 2016; 113(2): E182–E190. Doi:10.1073/pnas.1516618113.
4. Chertova E., Bess J.W., Jr. et al. Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), Is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus. J. Virol. 2002; 76(11): 5315–5325. Doi:10.1128/JVI.76.11.5315-5325.2002.
5. Vzorov A.N., Compans R.W. Assembly and release of SIV env proteins with full-length or truncated cytoplasmic domains. Virology. 1996; 221(1): 22–33. Doi:10.1006/viro.1996.0349.
6. Vzorov A.N., Tentsov Yu.Yu., Grigor’ev V.B. et al. Formation of virus-like particles by HIV-1 Gag proteins, expressed by a recombinant vaccinia virus. Mol. Biol. 1990; 24(6): 1666–1674. (In Russ.).
7. Spies C.P., Ritter G.D., Jr. et al. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J. Virol. 1994; 68(2): 585–591. Available at: https://jvi.asm.org/content/68/2/585.
8. Vzorov A.N., Compans R.W. Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization. J. Virol. 2000; 74(18): 8219–8225. Doi:10.1128/JVI.74.18.8219-8225.2000.
9. Vzorov A.N., Gernert K.M., Compans R.W. Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity. Virology. 2005; 332(1): 89–101. Doi:10.1016/j.virol.2004.10.044.
10. Vzorov A.N., Yang C., Compans R.W. An amphipathic sequence in the cytoplasmic tail of HIV-1 Env alters cell tropism and modulates viral receptor specificity. Acta Virol. 2015; 59(3): 209–220. Doi:10.4149/av_2015_03_209.
11. Ye L., Bu Z., Vzorov A. et al. Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain. J. Virol. 2004; 78(24): 13409–13419. Doi:10.1128/JVI.78.24.13409-13419.2004.
12. Moore P.L., Crooks E.T., Porter L. et al. Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1. J. Virol. 2006; 80(5): 2515–2528. Doi:10.1128/JVI.80.5.2515-2528.2006.
13. Parren P.W., Burton D.R., Sattentau Q.J. HIV-1 antibody — debris or virion? Nat. Med. 1997; 3(4): 366–367. Doi:10.1038/nm0497-366d.
14. Quan F.S., Sailaja G., Skountzou I. et al. Immunogenicity of virus-like particles containing modified human immunodeficiency virus envelope proteins. Vaccine. 2007; 25(19): 3841–3850. Doi:10.1016/j.vaccine.2007.01.107.
15. Lanteri M., Giordanengo V., Hiraoka N. et al. Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death. Glycobiology. 2003; 13(12): 909–918. Doi:10.1093/glycob/cwg110.
16. Munro J.B., Gorman J., Ma X. et al. Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions. Science. 2014; 346(6210): 759–763. Doi:10.1126/science.1254426.
17. Chahroudi A., Silvestri G. What pediatric nonprogressors and natural SIV hosts teach us about HIV. Sci. Transl. Med. 2016; 8(358): 358fs316. Doi:10.1126/scitranslmed.aaj1874.
18. Stacey A.R., Norris P.J., Qin L. et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed resp — onses in acute hepatitis B and C virus infections. J. Virol. 2009; 83(8): 3719–3733. Doi:10.1128/JVI.01844-08.
19. Grossman Z., Meier-Schellersheim M., Paul W.E., Picker L.J. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat. Med. 2006; 12(3): 289–295. Doi:10.1038/nm1380.